IPO Trending
SUDARSHANSME / BSEListed

Sudarshan Pharma Industries Limited

Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.

₹71 - ₹731.06x sub
Listed Price73.00
Listing Gain+0.00%
TimelineBookbuilding IPO
Open09 Mar 2023
Close14 Mar 2023
Allotment18 Mar 2023
Listing20 Mar 2023

Quota Reservation Portions

QIBPortion: 13,02,400 shares
18.98%
Nii (hni)Portion: 15,64,800 shares
22.8%
RetailPortion: 36,51,200 shares
53.21%
Market MakerPortion: 3,44,000 shares
5.01%

Minimum Application Bracket Matrix

Retail1 lots / 1,600 shares
₹1,16,800
HNI2 lots / 3,200 shares
₹2,33,600

About the Company

Incorporated in 2008, Sudarshan Pharma Industries Limited (SPIL) is a Mumbai-based company engaged in contract manufacturing, import, export, and supply of specialty chemicals, Active Pharmaceutical Ingredients (APIs), and intermediates. The company sources and supplies generic formulations by outsourcing manufacturing facilities from domestic and international suppliers based on client requirements. Its products find applications across industries such as pharmaceuticals, paints, food, and adhesives. SPIL also supplies medicines and pharma formulations to hospitals, NGOs, government bodies, and healthcare institutions under its own brand, offering around 50 formulations in tablets, capsules, ointments, and injectables. With a strong sales and distribution network across five states, the company markets its products ethically in both Indian and international markets, while also offering formulation development, quality control, and customized pharma solutions.

Company Promoters

Mr. Hemal Vasantrai MehtaMr. Sachin Vasantrai Mehta